Skip to main content

SPOT - Synthesis of Pretargeted Oncology Theranostics

Project description

Improvement of tumour-targeting specificity and treatment initialisation

Prompt cancer diagnosis and treatment initialisation are closely linked to disease outcome. The EU-funded SPOT project is developing an innovative approach for cancer imaging and treatment that exploits the combinatorial use of small antibody fragments and nanoparticles. The small antibody fragments, which exhibit highly specific targeting capacities and are capable of deep tissue penetration, will serve as guides for bioimaging and drug-delivering nanoparticles. Click reactions between moieties attached to small antibody fragments and nanoparticles ensure the specific visualisation of tumor tissue as well as delivery of nanoparticle payload at the tumour site. The SPOT approach is expected to overcome the limitations associated with the direct conjugation of drugs, imaging probes or drug-delivering nanoparticles to antibodies, offering an advanced strategy for tumour imaging and treatment. The approach also intents to achieve a crucial time gain between diagnosis and treatment initialisation.

Call for proposal

H2020-MSCA-IF-2019
See other projects for this call

Funding Scheme

MSCA-IF-EF-ST - Standard EF
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

UNIVERSIDAD COMPLUTENSE DE MADRID
Address
Avenida De Seneca 2
28040 Madrid
Spain
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 160 932,48